AngioDynamics | ANGO - Operating Expenses

Stock Price
10.81
Daily Change
-0.18 -1.64%
Monthly
2.37%
Yearly
14.88%
Q1 Forecast
11.09

AngioDynamics reported $81.98M in Operating Expenses for its fiscal quarter ending in February of 2025.





Operating Expenses Change Date
Accuray USD 37.18M 567K Dec/2024
AngioDynamics USD 81.98M 1.96M Feb/2025
Artivion USD 56.62M 195K Sep/2024
AtriCure USD 138.01M 3.95M Dec/2025
Boston Scientific USD 4.04B 18M Dec/2025
Edwards Lifesciences USD 1.2B 71.3M Dec/2025
ICU Medical USD 514.62M 4.48M Dec/2025
Inogen USD 49.14M 665K Sep/2024
J&J USD 18.97B 2.38B Dec/2025
Medtronic USD 7.28B 16M Dec/2025
Merit Medical Systems USD 339.74M 1.8M Dec/2025
Mesa Laboratories USD 33.98M 2.03M Dec/2024
Orthofix International USD 10.89M 209.57M Sep/2024
Smiths GBP 1.37B 80M Dec/2025
Surmodics USD -245.35M 363.49M Sep/2024
Tandem Diabetes Care USD 282.09M 9.97M Dec/2025
Teleflex USD 532.64M 3.29B Dec/2025
Terumo JPY 252.74B 22.88B Dec/2025
Trinity Biotech USD 14.82M 7.81M Sep/2025